Vuong Trieu insider trades

Open-market stock purchases and sales by Vuong Trieu, CHAIRMAN AND CEO at Oncotelic Therapeutics, Inc, from SEC Form 4 filings since Oct 29, 2013.

Track record: 76% of 21 scored buys are up 5% or more since purchase, averaging +29%.

Recent trades

DateStockTradeValue
Jun 24, 2026OTLC Oncotelic Therapeutics, IncBought$5.2K
Jun 23, 2026OTLC Oncotelic Therapeutics, IncBought$3.4K
Jun 22, 2026OTLC Oncotelic Therapeutics, IncBought$2.9K
Jun 17, 2026OTLC Oncotelic Therapeutics, IncBought$10.7K
Jun 15, 2026OTLC Oncotelic Therapeutics, IncBought$4.3K
Jan 22, 2026OTLC Oncotelic Therapeutics, IncBought (not open market)—
Nov 17, 2025OTLC Oncotelic Therapeutics, IncBought (not open market)—

Companies traded

  • OTLC Oncotelic Therapeutics, Inc: 23 buys, last Jun 24, 2026
  • MATN Mateon Therapeutics Inc: 2 buys, last Nov 19, 2020
  • MRNA Marina Biotech, Inc: 6 buys, last Oct 1, 2018
  • SRNE Sorrento Therapeutics, Inc: other filings, last Oct 29, 2013

Get free alerts when Vuong Trieu files a new trade →